Development of a telephone survey system for patients with amyotrophic lateral sclerosis using the ALSFRS-R (Japanese version) and application of this system in a longitudinal multicenter study

Brain and Nerve

Volumn 63, Issue 5, 2011, Pages 491-496

  Atsuta, Naoki ^a   Watanabe, Hirohisa ^a   Ito, Mizuki ^a   Nakamura, Ryoichi ^b   Senda, Jo ^a   Kato, Shigenori ^b   Sobue, Gen ^b  

^a NAGOYA UNIVERSITY HOSPITAL   (Japan)

^b NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Amyotrophic lateral sclerosis; Caregiver; Japanese Consortium for Amyotrophic Lateral Sclerosis research (JaCALS); Revised Amyotrophic Lateral Sclerosis Functional Rating Scale (ALSFRS R); Telephone

Indexed keywords

ADULT; AMYOTROPHIC LATERAL SCLEROSIS; AMYOTROPHIC LATERAL SCLEROSIS FUNCTIONAL RATING SCALE; ARTICLE; CAREGIVER; CLINICAL ARTICLE; CORRELATION COEFFICIENT; DAILY LIFE ACTIVITY; HUMAN; LONGITUDINAL STUDY; PROGNOSIS; RATING SCALE; RELIABILITY; TELEPHONE;

ACTIVITIES OF DAILY LIVING; AGED; AMYOTROPHIC LATERAL SCLEROSIS; COHORT STUDIES; FEMALE; HEALTH SURVEYS; HUMANS; INTERVIEWS AS TOPIC; JAPAN; LANGUAGE; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; MULTICENTER STUDIES AS TOPIC; PROSPECTIVE STUDIES; REPRODUCIBILITY OF RESULTS; TELEPHONE;

EID: 79955787186     PISSN: 18816096     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. No To Shinkei 53: 346-355, 2001
2. The ALS CNTF treatment study (ACTS) phase III Study Group: The Amyotrophic Lateral Sclerosis Functional Rating Scale. Assessment of activities of daily living in patients with amyotrophic lateral sclerosis. Arch Neurol 53: 141-147, 1996
3. Cedarbaum JM, Stambler N, Malta E, Fuller C, Hilt D, et al: The ALSFRS-R: a revised ALS functional rating scale that incorporates assessments of respiratory function. J Neurol Sci 169: 13-21, 1999 (Pubitemid 29502501)
4. Kaufmann P, Levy G, Thompson JL, Delbene ML, Battista V, et al: The ALSFRSr predicts survival time in an ALS clinic population. Neurology 64: 38-43, 2005 (Pubitemid 40082934)
5. Kimura F, Fujimura C, Ishida S, Nakajima H, Furutama D, et al: Progression rate of ALSFRS-R at time of diagnosis predicts survival time in ALS. Neurology 66: 265-267, 2006 (Pubitemid 43970171)
6. Gordon PH, Moore DH, Miller RG, Florence JM, Verheijde JL, et al: Efficacy of minocycline in patients with amyotrophic lateral sclerosis: a phase III randomised trial. Lancet Neurol 6: 1045-1053, 2007 (Pubitemid 350116691)
7. Aggarwal SP, Zinman L, Simpson E, McKinley J, Jackson KE, et al: Safety and efficacy of lithium in combination with riluzole for treatment of amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled trial. Lancet Neurol 9: 481-488, 2010
8. Yoshino H, Kimura A: Investigation of the therapeutic effects of edaravone, a free radical scavenger, on amyotrophic lateral sclerosis (Phase II study). Amyotroph Lateral Scler 7: 241-245, 2006
9. Kasarskis EJ, Dempsey-Hall L, Thompson MM, Luu LC, Mendiondo M, et al: Rating the severity of ALS by caregivers over the telephone using the ALSFRS-R. Amyotroph Lateral Scler Other Motor Neuron Disord 6: 50-54, 2005 (Pubitemid 40668248)
10. Mannino M, Cellura E, Grimaldi G, Volanti P, Piccoli F, et al: Telephone follow-up for patients with amyotrophic lateral sclerosis. Eur J Neurol 14: 79-84, 2007 (Pubitemid 46088041)
11. Kaufmann P, Levy G, Montes J, Buchsbaum R, Barsdorf AI, et al: Excellent inter-rater, intra-rater, and telephone-administered reliability of the ALSFRS-R in a multicenter clinical trial. Amyotroph Lateral Scler 8: 42-46, 2007 (Pubitemid 46322939)